經歷

國軍金門醫院 藥劑官(0911225-0930118)
署立桃園醫院 藥師(0930201-0930430)
承安醫院籌備處 員工(0930501-0930731)
承安醫院 藥師(0930801-0940831)
三軍總醫院臨床藥學部調劑科住院藥局 藥師(0940902-0970616)
三軍總醫院臨床藥學部臨藥科調製組 藥師(0970916-1100731)
三軍總醫院臨床藥學部臨藥科調製組 副組長(1030501-1050131)
三軍總醫院臨床藥學部臨藥科 總藥師 (1100801-迄今)
營養治療委員會委員(0990101-0991231)
營養治療審議會委員(1040601-1041231)

專長學科

癌症藥物治療、藥物分析、藥物化學
臺灣臨床藥學會醫院藥師專業進階P3資格
臺灣藥學會醫院藥學實習指導教師
放射性物質或可發生游離輻射設備操作人員輻射安全證書
台灣靜脈暨腸道醫學會營養醫療專科藥師證書

發表著作

1.Liu CT, Kao LT, Shih JH, Chien WC, Chiu CH, Ma KH, Huang YS, Cheng CY, Shiue CY, Li IH. The effect of dextromethorphan use in Parkinson's disease: A 6-hydroxydopamine rat model and population-based study. Eur J Pharmacol. 2019 Nov 5;862:172639. doi: 10.1016/j.ejphar.2019.172639. Epub 2019 Sep 3. PMID: 31491406.
2.Liu CT, Huang YS, Chen HC, Ma KH, Wang CH, Chiu CH, Shih JH, Kang HH, Shiue CY, Li IH. Evaluation of brain SERT with 4-[18F]-ADAM/micro-PET and hearing protective effects of dextromethorphan in hearing loss rat model. Toxicol Appl Pharmacol. 2019 Sep 1;378:114604. doi: 10.1016/j.taap.2019.114604. Epub 2019 May 30. PMID: 31153898.
3.Won SJ, Liu CT, Tsao LT, Weng JR, Ko HH, Wang JP, Lin CN. Synthetic chalcones as potential anti-inflammatory and cancer chemopreventive agents. Eur J Med Chem. 2005 Jan;40(1):103-12. doi: 10.1016/j.ejmech.2004.09.006. PMID: 15642415.
4.Ko HH, Hsieh HK, Liu CT, Lin HC, Teng CM, Lin CN. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation. J Pharm Pharmacol. 2004 Oct;56(10):1333-7. doi: 10.1211/0022357044247. PMID: 15482650.
5.Ko HH, Tsao LT, Yu KL, Liu CT, Wang JP, Lin CN. Structure-activity relationship studies on chalcone derivatives. the potent inhibition of chemical mediators release. Bioorg Med Chem. 2003 Jan 2;11(1):105-11. doi: 10.1016/s0968-0896(02)00312-7. PMID: 12467713.